1-3 of 3 results for primarymember:"Jonathan Reynolds"
Librarians' tools
- Search time
- 0.217 seconds
- Solr query time
- 0.002 seconds
- Search query
- primarymember:"Jonathan Reynolds"
- We searched for
- primaryMember_ses:303201
Type
House
Session
Year
Department
Member
Primary member
Answering member
More
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the time taken for his Department to investigate the effects of valproate in pregnancy; and whether he plans to launch an independent review of that matter.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the time taken for his Department to investigate the effects of valproate in pregnancy; and whether he plans to launch an independent review of that matter.
The report of the Independent Medicines and Medical Devices Safety Review was published on 8 July and one of the interventions it considered was sodium valproate. The Government has received the report and is carefully considering its recommendations. An update will be provided in due course.
The Medicines and Healthcare products Regulatory Agency (MHRA) is developing a valproate registry, which aims to monitor the use of valproate in girls and women in the United Kingdom, and to identify and monitor outcomes in any children born to women on valproate as well as ensuring compliance with the current regulatory requirements. There has been a gradual decline in prescribing of valproate to women of childbearing age over several years, and the MHRA is working with the National Health Service and professional regulators to ensure that women with epilepsy receive the healthcare they require.
To ask the Secretary of State for Health and Social Care, what proportion of patients of child and adult mental health services administered by the NHS have (a) fetal valproate spectrum disorder, (b) fetal valproate syndrome, (c) fetal anti-convulsant syndrome and (d) autistic spectrum disorder primarily caused by valproate in...
To ask the Secretary of State for Health and Social Care, what proportion of patients of child and adult mental health services administered by the NHS have (a) fetal valproate spectrum disorder, (b) fetal valproate syndrome, (c) fetal anti-convulsant syndrome and (d) autistic spectrum disorder primarily caused by valproate in...
We are not able to provide this information as data is not held on all patients with fetal valproate spectrum disorder, fetal valproate syndrome, fetal anti-convulsant syndrome and autistic spectrum disorder.
To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of providing social care for children diagnosed with fetal valproate spectrum disorder as a result of their mother being prescribed valproate in pregnancy in the last year...
To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of providing social care for children diagnosed with fetal valproate spectrum disorder as a result of their mother being prescribed valproate in pregnancy in the last year...
The Department does not hold data on the cost of providing social care to children diagnosed with fetal valproate spectrum disorder.
The Department for Education is responsible for the legal and policy frameworks within which children’s social care services operate. The Ministry of Housing, Communities and Local Government provides funding to local authorities for children’s services.